Prime Medicine, Inc. PRME
Institutional shares held
55.9 Million
182K
calls
211K
puts
Total value of holdings
$212M
$690K
calls
$800K
puts
Market Cap
$363M
95,730,200
Shares Out.
Institutional ownership
58.4%
# of Institutions
130
We take great care to ensure that the data presented and summarized in this overview for Prime Medicine, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PRME
View all-
Alphabet Inc. Mountain View, CA15.1MShares$57.1 Million2.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.48MShares$24.6 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.11MShares$19.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$13.7 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.32MShares$8.8 Million0.05% of portfolio
-
Redmile Group, LLC San Francisco, CA2.07MShares$7.86 Million0.62% of portfolio
-
Mwg Management Ltd. Washington, DC1.79MShares$6.79 Million8.53% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.59MShares$6.04 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.1.59MShares$6.02 Million0.04% of portfolio
-
Casdin Capital, LLC New York, NY1.57MShares$5.94 Million0.54% of portfolio
Latest Institutional Activity in PRME
Top Purchases
Top Sells
About PRME
Insider Transactions at PRME
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 01
2025
|
Gv 2021 Gp, L.L.C. |
BUY
Open market or private purchase
|
Indirect |
1,500,000
+31.5%
|
$4,500,000
$3.3 P/Share
|
|
Aug 01
2025
|
Robert Nelsen Director |
BUY
Open market or private purchase
|
Indirect |
3,030,300
+32.72%
|
$9,090,900
$3.3 P/Share
|
|
Aug 01
2025
|
Arch Venture Partners X, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,030,300
+32.72%
|
$9,090,900
$3.3 P/Share
|
|
Aug 01
2025
|
Arch Venture Partners Xii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,030,300
+32.72%
|
$9,090,900
$3.3 P/Share
|
|
Jun 30
2025
|
David R. Liu > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
21,000
+0.1%
|
$42,000
$2.52 P/Share
|
|
Jun 23
2025
|
David R. Liu > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
21,000
+0.1%
|
$42,000
$2.16 P/Share
|
|
Jun 16
2025
|
David R. Liu > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
21,000
+0.1%
|
$21,000
$1.49 P/Share
|
|
Jun 11
2025
|
David R. Liu > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
21,000
+0.1%
|
$21,000
$1.6 P/Share
|
|
May 21
2025
|
Ann L. Lee Chief Technical Officer |
BUY
Open market or private purchase
|
Direct |
100,000
+50.0%
|
$100,000
$1.13 P/Share
|
|
May 21
2025
|
Allan Reine Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
125,000
+50.0%
|
$125,000
$1.18 P/Share
|
|
May 20
2025
|
Richard Brudnick Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+50.0%
|
$20,000
$1.19 P/Share
|
|
Oct 08
2024
|
Keith Michael Gottesdiener Director |
BUY
Bona fide gift
|
Indirect |
226,925
+24.96%
|
-
|
|
Oct 08
2024
|
Keith Michael Gottesdiener Director |
SELL
Bona fide gift
|
Indirect |
226,925
-81.87%
|
-
|
|
Jun 05
2024
|
Keith Michael Gottesdiener Director |
BUY
Bona fide gift
|
Indirect |
250,000
+47.42%
|
-
|
|
Jun 05
2024
|
Keith Michael Gottesdiener Director |
SELL
Bona fide gift
|
Direct |
250,000
-9.76%
|
-
|
|
Feb 15
2024
|
Robert Nelsen Director |
BUY
Open market or private purchase
|
Indirect |
3,200,000
+50.0%
|
$19,200,000
$6.25 P/Share
|
|
Feb 15
2024
|
Arch Venture Partners X, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,200,000
+50.0%
|
$19,200,000
$6.25 P/Share
|
|
Feb 15
2024
|
Arch Venture Partners Xii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,200,000
+50.0%
|
$19,200,000
$6.25 P/Share
|
|
Nov 11
2023
|
Keith Michael Gottesdiener Director |
SELL
Bona fide gift
|
Indirect |
5,000
-15.54%
|
-
|
|
Nov 11
2023
|
Keith Michael Gottesdiener Director |
SELL
Bona fide gift
|
Direct |
7,500
-0.29%
|
-
|
Last 12 Months Summary
Buy / Acquisition
11.1M
Shares
From
9
Insiders
| Open market or private purchase | 10.9M shares |
|---|---|
| Bona fide gift | 227K shares |
Sell / Disposition
227K
Shares
From
1
Insiders
| Bona fide gift | 227K shares |
|---|